Water Losses 101: A Discussion of Common Causes of Water Losses and How to Investigate Them – Part 1 The newest episode of the Subro Sessions podcast, is hosted by Gus Sara, Partner, and Michael DeBona, Counsel, who are… Read More → June 20, 2024
Amtrak Confirms Data Breach Affecting Guest Rewards Accounts On June 14, 2024, the National Railroad Passenger Corporation d/b/a Amtrak (“Amtrak”) filed a notice of data breach with the… Read More → June 20, 2024
Globe Life Confirms Cyber Attack and Investigates “Likely” Data Breach On June 14, 2024, Globe Life Inc. filed a notice with the Securities and Exchange Commission after experiencing a cybersecurity… Read More → June 20, 2024
Sirva Data Breach Affects Consumers’ Confidential Information Recently, Sirva, Inc. filed a notice of data breach with the Attorney General of Massachusetts after discovering that information that… Read More → June 20, 2024
Scout Energy Partners Notifies Consumers of Early 2024 Data Breach On June 14, 2024, Scout Energy Management LLC (“Scout Energy Partners”) filed a notice of data breach with the Attorney… Read More → June 20, 2024
What’s it to You? Justice Scalia’s 41-Year-Old Gatekeeping Question on “Standing” Influences Court to Uphold FDA’s Regulation of Mifepristone Mifepristone is safe for now. On June 13, 2024, the Supreme Court unanimously held that the plaintiffs — doctors and… Read More → June 19, 2024
Developments Toward Standardizing AI ‘Red Teaming’ AI “red teaming” involves simulating attacks on AI systems to uncover vulnerabilities and enhance security. It is becoming an increasingly… Read More → June 19, 2024
Spotlight On: Neulasta® (pegfilgrastim) / Fulphila® (pegfilgrastim-jmdb) / Udenyca® (pegfilgrastim-cbqv) / Ziextenzo® (pegfilgrastim-bmez) / Nyvepria®(pegfilgrastim-apgf) / Fylnetra™ (pegfilgrastim-apgf) / Stimufend® (pegfilgrastim-fpgk) – June 2024 Pegfilgrastim Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in… Read More → June 19, 2024
Litigation Minute: State Statutes and the Private Right of Action (Generative AI Series: Part Two of Three) What You Need To Know In A Minute Or Less – Class action litigation challenging generative artificial intelligence (AI) has… Read More → June 19, 2024
Spotlight On: Actemra® (tocilizumab) / Tofidence™ (tocilizumab-bavi) / Tyenne® (tocilizumab-aazg) – June 2024 Tocilizumab Challenged Claim Types in IPRs: Claims are counted in each IPR, so claims from the same patent challenged in… Read More → June 19, 2024